Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | L-Tyrosine | HCID 6057 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | L-Tyrosine, N-(1,1-dimethylethoxy)carbonyl- | HCID 117439 | — |
| Reactant | HCID 46878601 | HCID 46878601 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 57053813 | HCID 57053813 | — |
Reaction Steps
The synthesis of Tyr derivative for iodo-labeling was conducted by the method of Tamura et al. (T. Tamura et al., Anal. Biochem. 216, 335-344 (1994)) (refer to FIG. 4.). That is, 30 μmols of (Gal)3 or (GalNAc)3 were dissolved in 3.6 ml of dimethylformamide, and 1.13 g of Boc-Tyr-NTH (supplied by Sigma) were added thereto. The solution was stirred at 50° C. for 5 hours. After the reaction solution was cooled, 1 N NaOH was added thereto, and a precipitate was removed through centrifugation. The supernatant was added to a Sephadex G-25 column (supplied by Pharmacia) which had been equilibrated with 1% (w) of pyridine and acetic acid to obtain a Tyr-Boc derivative fraction monitored at 280 nm. The fraction obtained was freeze-dried, and then dissolved again in a 0.1% TFA solution. The solution was purified through reversed-phase HPLC using an “Inertsil ODS-2” column (4.6×150 mm, supplied by GL Science Inc.) to form 14.7 mg of a Tyr-Boc derivative ((Gal)3-Tyr-Boc) and 28.9 mg of a Tyr-Boc derivative ((GalNAc)3-Tyr-Boc) having a peak purity of 90% or more. The structures of the products were identiried through electrospray ionization mass spectrometry (ESI-MS).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06620916B1 |
|---|
| Source dataset | uspto-grants-2003_09 |
|---|
| ORD ID | ord-37cb158a7fd449e6841fe9df4490a9d6 |
|---|
| Source note | uspto-grants-2003_09 |
|---|